Heme oxygenase-1, carbon monoxide, and bilirubin induce tolerance in recipients toward islet allografts by modulating T regulatory cells

FASEB Journal

Volumn 21, Issue 13, 2007, Pages 3450-3457

  Lee, Soo Sun ^a   Gao, Wenda ^a   Mazzola, Silvia ^b   Thomas, Michael N ^a   Csizmadia, Eva ^a   Otterbein, Leo E ^a   Bach, Fritz H ^a   Wang, Hongjun ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Allograft survival; Islet transplantation

Indexed keywords

BILIRUBIN; CARBON MONOXIDE; CD4 ANTIGEN; HEME OXYGENASE 1; INTERLEUKIN 2 RECEPTOR ALPHA; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN SPECIFICITY; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CONTROLLED STUDY; GRAFT SURVIVAL; IMMUNOGENICITY; IMMUNOMODULATION; MALE; MOUSE; NONHUMAN; PANCREAS ISLET TRANSPLANTATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECIPIENT; REGULATORY T LYMPHOCYTE; TRANSPLANTATION TOLERANCE;

ANIMALS; BILIRUBIN; CARBON MONOXIDE; FORKHEAD TRANSCRIPTION FACTORS; HEME OXYGENASE (DECYCLIZING); IMMUNE TOLERANCE; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; LYMPHOCYTE CULTURE TEST, MIXED; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, INBRED DBA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR BETA; TRANSPLANTATION, HOMOLOGOUS;

EID: 35948994573     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.07-8472com     Document Type: Article

References (39)

1. Ryan, E. A., Paty, B. W., Senior, P. A., and Shapiro, A. M. (2004) Risks and side effects of islet transplantation. Curr. Diab. Rep. 4, 304-309
2. Emerich, D. F. (2002) Islet transplantation for diabetes: current status and future prospects. Expert. Opin. Biol. Ther. 2, 793-803
3. Zhang, N., Su, D., Qu, S., Tse, T., Bottino, R., Balamurugan, A. N., Xu, J., Bromberg, J. S., and Dong, H. H. (2006) Sirolimus is associated with reduced islet engraftment and impaired beta-cell function. Diabetes 55, 2429-2436
4. Shapiro, A. M., Lakey, J. R., Ryan, E. A., Korbutt, G. S., Toth, E., Warnock, G. L., Kneteman, N. M., and Rajotte, R. V. (2000) Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N. Engl. J. Med. 343, 230-238
5. Nanji, S. A., and Shapiro, A. M. (2004) Islet transplantation in patients with diabetes mellitus: choice of immunosuppression. BioDrugs. 18, 315-328
6. Wang, H., Lee, S. S., Gao, W., Czismadia, E., McDaid, J., Ollinger, R., Soares, M. P., Yamashita, K., and Bach, F. H. (2005) Donor treatment with carbon monoxide can yield islet allograft survival and tolerance. Diabetes 54, 1400-1406
7. Wang, H., Lee, S. S., Dell'agnello, C., Tchipashvili, V., D'Avilla, J., Czismadia, E., Chin, B. Y., and Bach, F. H. (2005) Bilirubin can induce tolerance to islet allografts. Endocrinology 147, 762-768
8. Shevach, E. M. (2002) CD4+ CD25+ suppressor T cells: more questions than answers. Nat. Rev. Immunol. 2, 389-400
9. Dai, Z., Li, Q., Wang, Y., Gao, G., Diggs, L. S., Tellides, G., and Lakkis, F. G. (2004) CD4+CD25+ regulatory T cells suppress allograft rejection mediated by memory CD8+ T cells via a CD30-dependent mechanism. J. Clin. Invest. 113, 310-317
10. Lee, M. K. T., Moore, D. J., Jarrett, B. P., Lian, M. M., Deng, S., Huang, X., Markmann, J. W., Chiaccio, M., Barker, C. F., Caton, A. J., and Markmann, J. F. (2004) Promotion of allograft survival by CD4+CD25+ regulatory T cells: evidence for in vivo inhibition of effector cell proliferation. J. Immunol. 172, 6539-6544
11. Koksoy, S., Elpek, K. G., Yolcu, E. S., and Shirwan, H. (2005) Tolerance to rat heart grafts induced by intrathymic immunomodulation is mediated by indirect recognition primed CD4+CD25+ Treg cells. Transplantation 79, 1492-1497
12. Benghiat, F. S., Graca, L., Braun, M. Y., Detienne, S., Moore, F., Buonocore, S., Flamand, V., Waldmann, H., Goldman, M., and Le Moine, A. (2005) Critical influence of natural regulatory CD25+ T cells on the fate of allografts in the absence of immunosuppression. Transplantation 79, 648-654
13. Kingsley, C. I., Karim, M., Bushell, A. R., and Wood, K. J. (2002) CD25+CD4+ regulatory T cells prevent graft rejection: CTLA-4- and IL-10-dependent immunoregulation of alloresponses. J. Immunol. 168, 1080-1086
14. Trani, J., Moore, D. J., Jarrett, B. P., Markmann, J. W., Lee, M. K., Singer, A., Lian, M. M., Tran, B., Caton, A. J., and Markmann, J. F. (2003) CD25+ immunoregulatory CD4 T cells mediate acquired central transplantation tolerance. J. Immunol. 170, 279-286
15. Hara, M., Kingsley, C. I., Niimi, M., Read, S., Turvey, S. E., Bushell, A. R., Morris, P. J., Powrie, F., and Wood, K. J. (2001) IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo. J. Immunol. 166, 3789-3796
16. Graca, L., Thompson, S., Lin, C. Y., Adams, E., Cobbold, S. P., and Waldmann, H. (2002) Both CD4(+)CD25(+) and CD4(+)CD25(-) regulatory cells mediate dominant transplantation tolerance. J. Immunol. 168, 5558-5565
17. Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M., and Toda, M. (1995) Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155, 1151-1164
18. Huber, S., Schramm, C., Lehr, H. A., Mann, A., Schmitt, S., Becker, C., Protschka, M., Galle, P. R., Neurath, M. F., and Blessing, M. (2004) Cutting edge: TGF-beta signaling is required for the in vivo expansion and immunosuppressive capacity of regulatory CD4+CD25+ T cells. J. Immunol. 173, 6526-6531
19. Read, S., Malmstrom, V., and Powrie, F. (2000) Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation. J. Exp. Med. 192, 295-302
20. Tang, Q., Boden, E. K., Henriksen, K. J., Bour-Jordan, H., Bi, M., and Bluestone, J. A. (2004) Distinct roles of CTLA-4 and TGF-beta in CD4+CD25+ regulatory T cell function. Eur. J. Immunol. 34, 2996-3005
21. Kohyama, M., Sugahara, D., Sugiyama, S., Yagita, H., Okumura, K., and Hozumi, N. (2004) Inducible costimulator-dependent IL-10 production by regulatory T cells specific for self-antigen. Proc. Natl. Acad. Sci. U. S. A. 101, 4192-4197
22. Hori, S., Nomura, T., and Sakaguchi, S. (2003) Control of regulatory T cell development by the transcription factor Foxp3. Science 299, 1057-1061
23. Fontenot, J. D., Gavin, M. A., and Rudensky, A. Y. (2003) Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol. 4, 330-336
24. Choi, B. M., Pae, H. O., Jeong, Y. R., Kim, Y. M., and Chung, H. T. (2005) Critical role of heme oxygenase-1 in Foxp3-mediated immune suppression. Biochem. Biophys. Res. Commun. 327, 1066-1071
25. Pace, L., Rizzo, S., Palombi, C., Brombacher, F., and Doria, G. (2006) Cutting edge: IL-4-induced protection of CD4+CD25-Th cells from CD4+CD25+ regulatory T cell-mediated suppression. J. Immunol. 176, 3900-3904
26. Shevach, E. M., McHugh, R. S., Piccirillo, C. A., and Thornton, A. M. (2001) Control of T-cell activation by CD4+ CD25+ suppressor T cells. Immunol. Rev. 182, 58-67
27. Kryczek, I., Wei, S., Zou, L., Zhu, G., Mottram, P., Xu, H., Chen, L., and Zou, W. (2006) Cutting edge: induction of B7-H4 on APCs through IL-10: novel suppressive mode for regulatory T cells. J. Immunol. 177, 40-44
28. Maerten, P., Shen, C., Bullens, D. M., Van Assche, G., Van Gool, S., Geboes, K., Rutgeerts, P., and Ceuppens, J. L. (2005) Effects of interleukin 4 on CD25+CD4+ regulatory T cell function. J. Autoimmun. 25, 112-120
29. Xia, Z. W., Zhong, W. W., Xu, L. Q., Sun, J. L., Shen, Q. X., Wang, J. G., Shao, J., Li, Y. Z., and Yu, S. C. (2006) Heme oxygenase-1-mediated CD4+CD25high regulatory T cells suppress allergic airway inflammation. J. Immunol. 177, 5936-5945
30. Zelenay, S., Chora, A., Soares, M. P., and Demengeot, J. (2007) Heme oxygenase-1 is not required for mouse regulatory T cell development and function. Int. Immunol. 19, 11-18
31. Yamashita, K., Ollinger, R., McDaid, J., Sakahama, H., Wang, H., Tyagi, S., Csizmadia, E., Smith, N. R., Soares, M. P., and Bach, F. H. (2006) Heme oxygenase-1 is essential for and promotes tolerance to transplanted organs. [E-pub ahead of print] FASEB J. 10.1096/05-4791fje
32. Ricordi, C., Gray, D. W., Hering, B. J., Kaufman, D. B., Warnock, G. L., Kneteman, N. M., Lake, S. P., London, N. J., Socci, C., Alejandro, R., and et al. (1990) Islet isolation assessment in man and large animals. Acta. Diabetol. Lat. 27, 185-195
33. Molano, R. D., Pileggi, A., Berney, T., Poggioli, R., Zahr, E., Oliver, R., Ricordi, C., Rothstein, D. M., Basadonna, G. P., and Inverardi, L. (2003) Prolonged islet allograft survival in diabetic NOD mice by targeting CD45RB and CD154. Diabetes 52, 957-964
34. Kumagai, N., O'Neil, J. J., Barth, R. N., LaMattina, J. C., Utsugi, R., Moran, S. G., Yamamoto, S., Vagefi, P. A., Kitamura, H., Kamano, C., Sachs, D. H., and Yamada, K. (2002) Vascularized islet-cell transplantation in miniature swine. I. Preparation of vascularized islet kidneys. Transplantation 74, 1223-1230
35. Erdmann, K., Grosser, N., and Schroder, H. (2005) L-methionine reduces oxidant stress in endothelial cells: role of heme oxygenase-1, ferritin, and nitric oxide. AAPS J. 7, E195-E200
36. Bertuzzi, F., Marzorati, S., and Secchi, A. (2006) Islet cell transplantation. Curr. Mol. Med. 6, 369-374
37. Nakao, A., Neto, J. S., Kanno, S., Stolz, D. B., Kimizuka, K., Liu, F., Bach, F. H., Billiar, T. R., Choi, A. M., Otterbein, L. E., and Murase, N. (2005) Protection against ischemia/reperfusion injury in cardiac and renal transplantation with carbon monoxide, biliverdin and both. Am. J. Transplant 5, 282-291
38. Li, M., Peterson, S., Husney, D., Inaba, M., Guo, K., Kappas, A., Ikehara, S., and Abraham, N. G. (2007) Long-lasting expression of HO-1 delays progression of type I diabetes in NOD mice. Cell Cycle 6, 567-571
39. Pileggi, A., Molano, R. D., Berney, T., Cattan, P., Vizzardelli, C., Oliver, R., Fraker, C., Ricordi, C., Pastori, R. L., Bach, F. H., and Inverardi, L. (2001) Heme oxygenase-1 induction in islet cells results in protection from apoptosis and improved in vivo function after transplantation. Diabetes 50, 1983-1991